United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market (2026-2032) Outlook | Growth, Forecast, Size, Value, Share, Industry, Revenue, Companies, Analysis & Trends

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Size, Share & Growth Rate

The United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market was estimated at USD 404 Million in 2025 and is projected to reach USD 542 Million by 2032, growing at a CAGR of 4.3% from 2026 to 2032. This growth trajectory reflects a combination of the UAE's proactive healthcare initiatives and the increasing demand for swift and reliable diagnostic solutions across various settings. The ongoing commitment to enhancing healthcare accessibility further strengthens the market’s prospects, particularly in underserved areas.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Year-wise Growth Rate and Key Drivers

This graph highlights how the United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market has steadily grown over the years, supported by major growth factors.

The table below presents the year‑wise growth rates along with the key drivers influencing the market

Note - Market size estimations and growth projections presented in this report are based on 6Wresearch’s advanced forecasting approach, validated with industry datasets as of June 2026.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Synopsis

The infectious disease point-of-care testing market in the UAE has seen remarkable momentum recently, driven by heightened awareness of infectious diseases and the importance of rapid diagnosis. As healthcare providers increasingly incorporate POCT into their practices, the market is poised for substantial growth, addressing the need for timely diagnosis in diverse healthcare settings.

Looking ahead, the UAE’s infectious disease POCT market is set to benefit from ongoing innovations and technological advancements. These developments, paired with a robust healthcare framework, will not only enhance the speed and accuracy of testing but also enable healthcare professionals to manage infectious diseases more effectively, ultimately leading to improved patient outcomes.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Key Takeaways

• The market is driven by a proactive healthcare system focused on early disease detection and prevention.
• POCT facilitates rapid diagnosis, essential for effective management of infectious diseases such as COVID-19 and influenza.
• Growing demand for mobile and decentralized testing solutions is reshaping the diagnostics landscape.
• Regulatory compliance and quality assurance remain pivotal for the credibility of POCT devices.
• Lessons from the COVID-19 pandemic have catalyzed the adoption of rapid testing technologies.

Evaluation of Restraints in United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market

While the UAE infectious disease point-of-care testing market shows strong potential, several restraints are inhibiting its full growth. A primary concern is the stringent regulatory landscape, which mandates that POCT devices meet high standards of accuracy and reliability. Manufacturers must navigate complex compliance frameworks, necessitating a collaborative approach with healthcare authorities to achieve necessary certifications. Additionally, there is a pressing need for comprehensive training programs to equip healthcare professionals with the skills required to effectively utilize POCT technologies and interpret results accurately.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Trends

The UAE market is currently experiencing several trends that are shaping the demand for point-of-care testing. One prominent trend is the surge in digital health solutions, as telehealth and mobile health applications gain traction. These innovations facilitate the integration of POCT with telemedicine, allowing for remote diagnosis and consultation. Additionally, there is a growing emphasis on personalized medicine, prompting the development of tailored diagnostic tests that cater to specific patient needs. Another trend is the increasing collaboration between public health agencies and private companies to enhance diagnostic capabilities, ensuring timely responses to emerging infectious diseases.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Opportunities

The future of the UAE infectious disease point-of-care testing market is brimming with genuine opportunities for growth and investment. The increasing focus on preventive healthcare, bolstered by government initiatives, presents a fertile ground for expanding POCT applications. Moreover, the expansion of diagnostic services into remote and underserved areas creates an urgent demand for mobile and user-friendly testing solutions. As healthcare providers seek to enhance patient engagement and streamline workflows, developing innovative POCT products tailored to local needs will be paramount.

Government Initiatives in the United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market

The UAE government has implemented several initiatives aimed at bolstering the infectious disease point-of-care testing landscape. Key strategies include increased public spending on healthcare infrastructure and investments in advanced diagnostic technologies. Additionally, ongoing public health campaigns emphasize the importance of early detection and treatment of infectious diseases, encouraging healthcare providers to adopt POCT solutions. Collaboration with international health organizations to standardize testing protocols also plays a significant role in enhancing the quality and reliability of diagnostics.

Future Insights of the United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market

Looking ahead to 2026-2032, the UAE infectious disease point-of-care testing market is projected to continue its upward trajectory, underpinned by advancements in technology and increased healthcare investment. The integration of artificial intelligence and machine learning into diagnostic tools will likely enhance accuracy and speed, driving further adoption. Furthermore, as healthcare providers embrace data analytics, the insights gained will optimize testing strategies and improve patient care. Overall, the market is expected to evolve into a critical component of the UAE’s public health strategy.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Latest Developments (May 2025 - June 2026)

Recent developments in the UAE infectious disease point-of-care testing market indicate a rapid evolution toward greater efficiency and accessibility. The focus has shifted towards the integration of user-friendly technologies and solutions that cater to diverse healthcare settings, including remote areas. As healthcare facilities and agencies adapt to the lessons learned from the pandemic, initiatives aimed at enhancing rapid testing capabilities have become a priority, leading to strategic partnerships and innovative product launches.

United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market - Key Attractiveness of the Report

• 10 Years of Market Numbers
• Historical Data Starting from 2022 to 2025
• Base Year: 2025
• Forecast Data until 2032
• Key Performance Indicators Impacting the Market
• Major Upcoming Developments and Projects

Key Highlights of the Report:

• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Outlook
• Market Size of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market, 2025
• Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market, 2032
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Revenues & Volume for the Period 2022-2032F
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Trend Evolution
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Drivers and Challenges
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Price Trends
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Porter's Five Forces
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Industry Life Cycle
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Applications for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Tropical Disease for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Liver Disease for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Respiratory Disease for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Sexual Disorders for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Others for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Technologies for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Lateral Flow for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Flow-through for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Agglutination Assays for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Solid Phase for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By End-users for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Diagnostic Laboratories for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Hospitals for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Home-care Settings for the Period 2022-2032F
• Historical Data and Forecast of United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Market Revenues & Volume By Others for the Period 2022-2032F
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Import Export Trade Statistics
• Market Opportunity Assessment By Applications
• Market Opportunity Assessment By Technologies
• Market Opportunity Assessment By End-users
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Top Companies Market Share
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Competitive Benchmarking By Technical and Operational Parameters
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Company Profiles
• United Arab Emirates (UAE) Infectious Disease Point-of-care Testing Key Strategic Recommendations